Bellicum Pharmaceuticals Inc (BLCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2012 | 12-2006 | 12-2005 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 1,632 | N/A | N/A |
| TOTAL | $2,478 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 2,511 | N/A | N/A |
| Other Non-Current Assets | 198 | 0 | 0 |
| TOTAL | $2,709 | $N/A | $N/A |
| Total Assets | $5,186 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 90 | N/A | N/A |
| Accounts payable and accrued liabilities | 551 | 0 | 0 |
| Accrued Expenses | 437 | N/A | N/A |
| Other current liabilities | 106 | N/A | N/A |
| TOTAL | $2,222 | $N/A | $N/A |
| Non-Current Liabilities | |||
| Long Term Debt | 360 | N/A | N/A |
| Deferred Revenues | 1,039 | N/A | N/A |
| Other Non-Current Liabilities | 420 | 0 | 0 |
| TOTAL | $780 | $N/A | $N/A |
| Total Liabilities | $3,002 | $N/A | $N/A |
| Shareholders' Equity | |||
| Common Shares | 17 | N/A | N/A |
| Retained earnings | -21,010 | N/A | N/A |
| Other shareholders' equity | 21,658 | 0 | 0 |
| TOTAL | $2,185 | $N/A | $N/A |
| Total Liabilities And Equity | $5,186 | $0 | $0 |